Linda Burkly
EVP, CHIEF SCIENTIFIC OFFICER · Editas Medicine, Inc.
- 2025
- Sep 4, 2026
- 7
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Linda Burkly files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Gilmore Neil O'Neill - $80K in EDIT purchases and sales in the last 12 months
- Amy Parison - $6K in EDIT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Linda Burkly?
Linda Burkly is a corporate insider, tracked as EVP, CHIEF SCIENTIFIC OFFICER of Editas Medicine, Inc. (EDIT). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Linda Burkly submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Linda Burkly been buying or selling stock?
Recorded transactions: 0 open-market purchases and 6 open-market sales ($33K) across all tracked filings.
